Nurix Therapeutics (NRIX) Asset Utilization Ratio (2020 - 2025)
Nurix Therapeutics (NRIX) has disclosed Asset Utilization Ratio for 6 consecutive years, with 0.14 as the latest value for Q4 2025.
- On a quarterly basis, Asset Utilization Ratio rose 56.62% to 0.14 in Q4 2025 year-over-year; TTM through Nov 2025 was 0.14, a 56.62% increase, with the full-year FY2025 number at 0.12, up 16.24% from a year prior.
- Asset Utilization Ratio was 0.14 for Q4 2025 at Nurix Therapeutics, down from 0.16 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.24 in Q1 2024 to a low of 0.05 in Q2 2021.
- A 5-year average of 0.12 and a median of 0.1 in 2022 define the central range for Asset Utilization Ratio.
- Peak YoY movement for Asset Utilization Ratio: skyrocketed 163.05% in 2023, then tumbled 63.71% in 2025.
- Nurix Therapeutics' Asset Utilization Ratio stood at 0.06 in 2021, then surged by 43.73% to 0.09 in 2022, then surged by 163.05% to 0.23 in 2023, then crashed by 60.24% to 0.09 in 2024, then surged by 56.62% to 0.14 in 2025.
- Per Business Quant, the three most recent readings for NRIX's Asset Utilization Ratio are 0.14 (Q4 2025), 0.16 (Q3 2025), and 0.15 (Q2 2025).